The Problem:
Manufacturing control systems, process validation, and batch traceability depend on constant connectivity. An interruption can mean the loss of an entire batch, a finding in a regulatory audit, or worse, a reportable deviation to the FDA.
In an industry where every minute of production has critical value, and the regulator accepts no infrastructure excuses, connectivity cannot be a point of failure.
Advanced automation, digital twins, and cloud-based MES systems require stable, low-latency connectivity.
AI platforms for real-time anomaly detection, statistical process control, and equipment failure prediction.
Connected sensors that continuously report temperature, humidity, and environmental conditions.
Electronic records systems and digital signatures must always be available and traceable.
ERP systems and product lifecycle management are the modern operational standard in the industry.
DNA provides two completely independent internet routes, fiber-optic and microwave, with automatic failover in milliseconds. Automatic continuity means that when one route fails, the other takes over instantly and transparently, without any system detecting it as an interruption.
No error screens. No manual reconnection. No downtime window. The transition occurs before any application, sensor, or system registers an anomaly. No SCADA system goes down. No FDA report is interrupted. No IoT sensor loses communication.
With dedicated bandwidth and a documented SLA, DNA also facilitates the infrastructure audits that regulators require.
Benefits for pharmaceutical plants
SCADA and DCS systems are always connected: critical process control without interruptions.
Uninterrupted batch traceability: MES and ERP systems never lose communication during an audit.
24/7 cold chain monitoring: IoT sensors report in real time without outages.
Support for FDA and cGMP compliance: stable network infrastructure is documentable evidence in audits.
Connectivity between plants and headquarters: DNA enables continuous communication across multiple locations.
Dedicated bandwidth with CIR: guaranteed speed for large data transfers between systems
In pharmaceutical manufacturing, every minute of production has critical value. DNA guarantees that a network failure is never the reason for a batch deviation or a regulatory finding.
Yes. We can design a multi-site connectivity solution with DNA at each location, ensuring all plants remain connected to the central systems.
DNA provides the continuous availability infrastructure that FDA-regulated electronic records systems require. The SLA guaranteed network availability is valid documentation for audits.
Yes. DNA offers plans with symmetric CIR (same upload and download speed), designed for high-demand manufacturing environments.
